Description

Pyrimido[4,5-G]Quinazoline-4,9-Dione, 3,8-Dihydro-5,10-Dihydroxy-2,3,7,8-Tetramethyl- is a complex heterocyclic organic compound belonging to the quinazoline-dione class, serving as a high-value advanced pharmaceutical intermediate and a versatile scaffold for chemical synthesis. Its unique fused-ring structure makes it a critical building block for the research and development of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular architectures. This compound is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of complex molecules for drug discovery and process development.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting specific enzyme pathways.
• Chemical Research & Development: Serves as a sophisticated scaffold for medicinal chemistry, enabling the exploration of new chemical entities and structure-activity relationships (SAR).
• Organic Synthesis Building Block: Used in multi-step synthetic routes to construct complex polycyclic frameworks found in advanced materials or bioactive compounds.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and impurity profiling of related pharmaceutical products.
• Biochemical Research: Potential use in biochemical assays as a probe or inhibitor for studying biological mechanisms, given its specific heterocyclic structure.

Basic Information

Item	Details
Product Name	Pyrimido[4,5-G]Quinazoline-4,9-Dione, 3,8-Dihydro-5,10-Dihydroxy-2,3,7,8-Tetramethyl-
CAS No.	115705-61-8
Molecular Formula	C16H16N4O4
Molecular Weight	328.33 g/mol
Synonyms	3,8-Dihydro-5,10-dihydroxy-2,3,7,8-tetramethylpyrimido[4,5-g]quinazoline-4,9-dione; 2,3,7,8-Tetramethyl-3,8-dihydro-5,10-dihydroxypyrimido[4,5-g]quinazoline-4,9-dione; Pyrimido[4,5-g]quinazoline-4,9-dione, 3,8-dihydro-5,10-dihydroxy-2,3,7,8-tetramethyl-; 5,10-Dihydroxy-2,3,7,8-tetramethyl-3,8-dihydropyrimido[4,5-g]quinazoline-4,9-dione; CAS 115705-61-8
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems to ensure batch-to-batch consistency and high purity. All materials are characterized using modern analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment to support your R&D and regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	Yellow to light brown powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.